Literature DB >> 21147930

Morphologic changes associated with intrathecal catheters for direct delivery to the central nervous system in preclinical studies.

Mark T Butt1.   

Abstract

A retrospective analysis of microscopic evaluation data from control (device and/or saline-treated) animals in intrathecal studies in monkeys, dogs, sheep, and rats was conducted. The studies were performed by multiple testing facilities. All slide preparation and microscopic evaluation were conducted in the laboratory of the author. The data were of observations made at the level of the catheter tip, which typically was located in the intrathecal space near the thoracolumbar region of the spinal canal. The most common microscopic changes in control animals were meningeal infiltrates, catheter track (CT) inflammation, spinal cord compression (at the CT), CT fibrosis, spinal cord gliosis (at the CT), and spinal cord nerve fiber degeneration. Although variable between studies (even within species), in general the average severity of these findings was minimal or less in control animals. CT inflammatory mass/pyogranuloma formation, a known complication following the administration of morphine at higher concentrations/doses, was noted in 3 of 25 control dogs and 2 of 77 control monkeys. These data show that inflammatory mass/pyogranuloma formation may occur in control animals, and this occurrence is most common in dogs as compared to monkeys, sheep, and rats.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21147930     DOI: 10.1177/0192623310391679

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  11 in total

1.  Safety evaluation of chronic intrathecal administration of heparan N-sulfatase in juvenile cynomolgus monkeys.

Authors:  Richard W Pfeifer; Brian R Felice; Robert B Boyd; Mark T Butt; Juan A Ruiz; Michael W Heartlein; Pericles Calias
Journal:  Drug Deliv Transl Res       Date:  2012-06       Impact factor: 4.617

2.  Neurologic Complications Associated with Transdermal Placement of Intrathecal Catheters in Sheep.

Authors:  Gabrielle C Musk; Nolan J McDonnell; Mark Newman; Matthew W Kemp
Journal:  Comp Med       Date:  2018-04-19       Impact factor: 0.982

3.  Biocompatibility of the fiberoptic microneedle device chronically implanted in the rat brain.

Authors:  Yukitaka Kani; Jonathan Hinckley; John L Robertson; Jason M Mehta; Christopher G Rylander; John H Rossmeisl
Journal:  Res Vet Sci       Date:  2021-12-31       Impact factor: 2.534

4.  Role of meningeal mast cells in intrathecal morphine-evoked granuloma formation.

Authors:  Tony L Yaksh; Jeffery W Allen; Samantha L Veesart; Kjersti A Horais; Shelle A Malkmus; Miriam Scadeng; Joanne J Steinauer; Steve S Rossi
Journal:  Anesthesiology       Date:  2013-03       Impact factor: 7.892

5.  Accidental dural puncture, postdural puncture headache, intrathecal catheters, and epidural blood patch: revisiting the old nemesis.

Authors:  Roland Kaddoum; Faisal Motlani; Romeo N Kaddoum; Arvi Srirajakalidindi; Deepak Gupta; Vitaly Soskin
Journal:  J Anesth       Date:  2013-12-18       Impact factor: 2.078

6.  Mu Opioid Splice Variant MOR-1K Contributes to the Development of Opioid-Induced Hyperalgesia.

Authors:  Folabomi A Oladosu; Matthew S Conrad; Sandra C O'Buckley; Naim U Rashid; Gary D Slade; Andrea G Nackley
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

Review 7.  Current perspectives on intrathecal drug delivery.

Authors:  Michael M Bottros; Paul J Christo
Journal:  J Pain Res       Date:  2014-11-06       Impact factor: 3.133

8.  Intermittent convection-enhanced delivery of GDNF into rhesus monkey putamen: absence of local or cerebellar toxicity.

Authors:  Matthias Luz; Philip C Allen; John Bringas; Chris Boiko; Diane E Stockinger; Kristen J Nikula; Owen Lewis; Max Woolley; H Christian Fibiger; Krystof Bankiewicz; Erich Mohr
Journal:  Arch Toxicol       Date:  2018-05-22       Impact factor: 5.153

9.  Alfentanil: correlations between absence of effect upon subcutaneous mast cells and absence of granuloma formation after intrathecal infusion in the dog.

Authors:  Tony L Yaksh; Joanne J Steinauer; Samantha L Veesart; Shelle A Malkmus
Journal:  Neuromodulation       Date:  2012-11-21

10.  Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease).

Authors:  Martin L Katz; Joan R Coates; Christine M Sibigtroth; Jacob D Taylor; Melissa Carpentier; Whitney M Young; Fred A Wininger; Derek Kennedy; Brian R Vuillemenot; Charles A O'Neill
Journal:  J Neurosci Res       Date:  2014-06-17       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.